Thursday, May 31, 2012

Alvaro Pereira-Rico, MD's Posts

Medical Oncologist's Response to Luteinizing Hormone-Releasing Hormone (LH-RH) Agonist Study

Breast Cancer News Editor's Note: Science and health news outlet EurekAlert! published yesterday an interesting summary of a Lancet study on luteinizing hormone-releasing hormone (LH-RH) agonists, drugs that decrease the level of estrogen and other sex hormones in women.  LH-RH agonists for breast cancer treatment are used in Europe and... Read moreChevron